adjusted diluted earnings per share from continuing operations (a) (b)

quarterly, fiscal 2015 to present

$6.00

$5.00

$4.00

$3.00

$2.00

$1.00

$0.00

1Q

2Q

3Q

4Q

Year(e)

2015

2016(d)

2017(c)(d)

2018

2019

Fiscal Year

1Q

2Q

3Q

4Q

Year (e)

2019

$

1.53

$

1.82

$

1.36

2018

$

1.32

$

1.47

$

1.09

$

1.53

$

5.39

2017 (c) (d)

$

1.20

$

1.22

$

0.90

$

1.36

$

4.69

2016 (d)

$

1.28

$

1.22

$

1.04

$

1.45

$

5.00

2015

$

1.10

$

1.22

$

0.86

$

1.52

$

4.69

  1. Adjusted diluted earnings per share from continuing operations (Adjusted EPS), a non-GAAP financial measure, excludes the impact of certain items. Refer to the slide "reconciliation of non-GAAP Adjusted EPS" under "summary financials" at investors.target.com for a reconciliation of Adjusted EPS to GAAP EPS from continuing operations.
  2. Diluted earnings per share includes the incremental shares assumed to be issued upon the exercise of stock options and the incremental shares assumed to be issued under performance share and restricted stock unit arrangements.
  3. The fourth quarter and full year 2017 consisted of 14 weeks and 53 weeks, respectively, compared with 13 weeks and 52 weeks in the comparable periods presented.
  4. Beginning with the first quarter 2018, we adopted the new accounting standards for revenue recognition, leases, and pensions. We are presenting certain prior period results on a basis consistent with the new standards and conformed to the current period presentation. We provided additional information about the impact of the new accounting standards on previously reported financial information in a Form 8-K filed on May 11, 2018.
  5. Earnings per share was computed independently for each of the periods presented; therefore the sum of the earnings per share amounts for the quarters may not equal the total for the year.

Source: Target's Consolidated Financial Statements as filed with the U.S. Securities and Exchange Commission.

Last Updated: 11/20/2019

Attachments

  • Original document
  • Permalink

Disclaimer

Target Corporation published this content on 20 November 2019 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 20 November 2019 11:59:08 UTC